Iovance Biotherapeutics, Inc. (FRA:2LB)

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics had revenue of $67.46M USD in the quarter ending September 30, 2025, with 15.20% growth. This brings the company's revenue in the last twelve months to $250.43M, up 175.62% year-over-year. In the year 2024, Iovance Biotherapeutics had annual revenue of $164.07M with 13,698.99% growth.

• Revenue (ttm): $250.43M
• Revenue Growth: +175.62%
• P/S Ratio: 3.92
• Revenue / Employee: $298.84K
• Employees: 838
• Market Cap: 836.12M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	164.07M	162.88M	13,698.99%
Dec 31, 2023	1.19M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-